Eudaimonia Advisors LLC Organon & Co. Transaction History

Eudaimonia Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	SELL	$21.42 - $32.08 $54,578 - $81,739	-2,548 Reduced 21.74%	9,175 $215,000
Q4 2022 Jan 24, 2023	SELL	$23.31 - $28.61 $67,645 - $83,026	-2,902 Reduced 19.84%	11,723 $0
Q3 2022 Nov 03, 2022	SELL	$23.4 - $34.25 $31,075 - $45,484	-1,328 Reduced 8.32%	14,625 $342,000
Q2 2022 Aug 09, 2022	SELL	$31.66 - $38.9 $85,292 - $104,796	-2,694 Reduced 14.45%	15,953 $538,000
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $13,611 - $17,593	-447 Reduced 2.34%	18,647 $651,000
Q4 2021 Feb 14, 2022	BUY	$28.67 - $37.13 $547,424 - $708,960	19,094 New	19,094 $581,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Eudaimonia Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Eudaimonia Advisors LLC with notifications on news.